Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05839210 · ClinicalTrials.gov registry record · NA
Lifestyle Intervention of Food and Exercise for Lymphoma Survivors
A NA study of Non-Hodgkin Lymphoma and Hodgkin Lymphoma, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT05839210: Recruiting NA study of Non-Hodgkin Lymphoma and Hodgkin Lymphoma, sponsored by University of Miami.
NCT05839210 is a NA study of Non-Hodgkin Lymphoma and Hodgkin Lymphoma that is actively recruiting participants, run by University of Miami. The registered enrollment target is 140 participants, below the 166-participant average among 106 other Non-Hodgkin Lymphoma trials with a reported enrollment target (16% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05839210, a NA study of Non-Hodgkin Lymphoma and Hodgkin Lymphoma, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate if a mediterranean diet and exercise program for Lymphoma patients during chemotherapy can improve treatment completion and reduce treatment-related side effects.
Primary Outcome
Percentage of survivors who agree to participate out of the total number of participants recruited will be assessed using a threshold of greater than or equal to (\>=) 50-percent.
Conditions Studied
Interventions
- BEHAVIORAL LIFE-L Mediterranean Diet
- BEHAVIORAL LIFE-L Home-Based Exercise Program
- BEHAVIORAL Supportive Materials
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2023-04-26 |
| Est. Completion | 2026-10-31 |
| Phase | NA |
What NCT05839210 shows while recruiting
NCT05839210 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 166-participant average among 106 other Non-Hodgkin Lymphoma trials with a reported enrollment target (16% lower).
The record links to 2 conditions, with Non-Hodgkin Lymphoma appearing as the primary indexed condition, and to 3 interventions - of which LIFE-L Mediterranean Diet is the first listed.
NCT05839210 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05839210 about?
NCT05839210 is a clinical study titled "Lifestyle Intervention of Food and Exercise for Lymphoma Survivors". The purpose of this study is to investigate if a mediterranean diet and exercise program for Lymphoma patients during chemotherapy can improve treatment completion and reduce treatment-related side effects.
What is the current status of trial NCT05839210?
This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2023-04-26. Estimated completion is 2026-10-31.
What conditions does trial NCT05839210 study?
This clinical trial studies the following conditions: Non-Hodgkin Lymphoma, Hodgkin Lymphoma.
What interventions are being tested in trial NCT05839210?
The interventions under investigation include: LIFE-L Mediterranean Diet (BEHAVIORAL), LIFE-L Home-Based Exercise Program (BEHAVIORAL), Supportive Materials (BEHAVIORAL).
Who is sponsoring clinical trial NCT05839210?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05839210 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-Hodgkin Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05839210's enrollment target sits among peer trials
140 28th of 106 higher than 79 of 106 other Non-Hodgkin Lymphoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Non-Hodgkin Lymphoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Exercise Capacity With a Tailored Physical Activity Intervention
RECRUITING · NA
-
Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health
ACTIVE NOT RECRUITING · NA
-
Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma
ACTIVE NOT RECRUITING · NA
-
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT
COMPLETED · NA
-
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors
COMPLETED · NA
-
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI